Zepp Health (ZEPP) Competitors $46.88 +0.11 (+0.24%) As of 02:43 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ZEPP vs. DBD, PAR, VYX, EVLV, ATEN, CRSR, SSYS, CTLP, MITK, and ALLTShould you be buying Zepp Health stock or one of its competitors? The main competitors of Zepp Health include Diebold Nixdorf (DBD), PAR Technology (PAR), NCR Voyix (VYX), Evolv Technologies (EVLV), A10 Networks (ATEN), Corsair Gaming (CRSR), Stratasys (SSYS), Cantaloupe (CTLP), Mitek Systems (MITK), and Allot (ALLT). These companies are all part of the "computer hardware" industry. Zepp Health vs. Its Competitors Diebold Nixdorf PAR Technology NCR Voyix Evolv Technologies A10 Networks Corsair Gaming Stratasys Cantaloupe Mitek Systems Allot Diebold Nixdorf (NYSE:DBD) and Zepp Health (NYSE:ZEPP) are both computer hardware companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, media sentiment, profitability, dividends, risk and analyst recommendations. Do analysts rate DBD or ZEPP? Diebold Nixdorf currently has a consensus price target of $75.00, suggesting a potential upside of 26.03%. Zepp Health has a consensus price target of $60.23, suggesting a potential upside of 28.48%. Given Zepp Health's higher probable upside, analysts plainly believe Zepp Health is more favorable than Diebold Nixdorf.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Diebold Nixdorf 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33Zepp Health 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is DBD or ZEPP more profitable? Diebold Nixdorf has a net margin of -0.35% compared to Zepp Health's net margin of -38.81%. Diebold Nixdorf's return on equity of 7.92% beat Zepp Health's return on equity.Company Net Margins Return on Equity Return on Assets Diebold Nixdorf-0.35% 7.92% 2.20% Zepp Health -38.81%-24.19%-11.36% Which has more risk & volatility, DBD or ZEPP? Diebold Nixdorf has a beta of 1.68, indicating that its stock price is 68% more volatile than the S&P 500. Comparatively, Zepp Health has a beta of 1.33, indicating that its stock price is 33% more volatile than the S&P 500. Which has higher valuation & earnings, DBD or ZEPP? Diebold Nixdorf has higher revenue and earnings than Zepp Health. Diebold Nixdorf is trading at a lower price-to-earnings ratio than Zepp Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDiebold Nixdorf$3.75B0.58-$16.50M-$0.34-175.03Zepp Health$182.60M3.72-$75.73M-$4.83-9.71 Does the media favor DBD or ZEPP? In the previous week, Zepp Health had 3 more articles in the media than Diebold Nixdorf. MarketBeat recorded 6 mentions for Zepp Health and 3 mentions for Diebold Nixdorf. Diebold Nixdorf's average media sentiment score of 0.91 beat Zepp Health's score of 0.51 indicating that Diebold Nixdorf is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Diebold Nixdorf 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Zepp Health 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals hold more shares of DBD or ZEPP? 97.0% of Diebold Nixdorf shares are held by institutional investors. Comparatively, 52.6% of Zepp Health shares are held by institutional investors. 0.3% of Diebold Nixdorf shares are held by insiders. Comparatively, 36.0% of Zepp Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. SummaryDiebold Nixdorf beats Zepp Health on 12 of the 17 factors compared between the two stocks. Get Zepp Health News Delivered to You Automatically Sign up to receive the latest news and ratings for ZEPP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ZEPP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZEPP vs. The Competition Export to ExcelMetricZepp HealthMEDICAL INFO SYS IndustryMedical SectorNYSE ExchangeMarket Cap$684.18M$2.17B$5.75B$21.53BDividend YieldN/AN/A5.88%3.49%P/E Ratio-9.7737.4777.0130.00Price / Sales3.7210.47528.6551.62Price / CashN/A57.9937.2024.77Price / Book2.6911.3313.964.55Net Income-$75.73M-$64.84M$3.29B$999.02M7 Day Performance-8.04%-0.43%1.38%2.11%1 Month Performance39.98%1.84%5.13%5.37%1 Year Performance1,316.31%33.93%84.67%14.63% Zepp Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZEPPZepp Health2.3982 of 5 stars$46.88+0.2%$60.23+28.5%+1,280.2%$684.18M$182.60M-9.771,230Short Interest ↑DBDDiebold Nixdorf4.4685 of 5 stars$60.81+1.5%$75.00+23.3%+40.5%$2.19B$3.75B-178.8521,000PARPAR Technology1.8922 of 5 stars$47.93-0.8%$78.43+63.6%-24.4%$1.96B$418.02M-21.301,585VYXNCR Voyix1.8154 of 5 stars$13.11-1.5%$14.20+8.3%-4.0%$1.84B$2.68B1.8414,000Positive NewsEVLVEvolv Technologies1.788 of 5 stars$8.27+2.6%$8.88+7.3%+99.8%$1.39B$103.86M-15.04170News CoverageOptions VolumeATENA10 Networks4.4783 of 5 stars$17.48-0.9%$22.00+25.9%+28.0%$1.27B$261.70M25.71580Positive NewsCRSRCorsair Gaming3.8348 of 5 stars$8.90+0.7%$9.83+10.5%+29.9%$937.37M$1.32B-10.992,567Positive NewsSSYSStratasys3.101 of 5 stars$10.30+0.6%$14.33+39.2%+32.9%$871.35M$572.46M-7.691,779Positive NewsShort Interest ↑CTLPCantaloupe2.3264 of 5 stars$10.83+0.2%$12.24+13.0%+70.9%$792.26M$268.60M13.71220MITKMitek Systems3.4749 of 5 stars$9.98+1.7%$13.50+35.3%+16.1%$447.80M$178.13M30.24450ALLTAllot1.6152 of 5 stars$8.73+3.1%N/A+207.5%$394.12M$92.19M-174.60740Positive NewsGap Down Related Companies and Tools Related Companies Diebold Nixdorf Alternatives PAR Technology Alternatives NCR Voyix Alternatives Evolv Technologies Alternatives A10 Networks Alternatives Corsair Gaming Alternatives Stratasys Alternatives Cantaloupe Alternatives Mitek Systems Alternatives Allot Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ZEPP) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zepp Health Corporation Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Zepp Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
